CME’s Record Quarter Meets a Regulatory Waiting Room
Volume and collateral savings hit records, but the two products management spent the summer defending—Compute Futures and perpetuals—are no closer to trading.
CME · Earnings Call · 2026-10-21
The record is real; the rerating is not
CME’s third quarter was, by the numbers, a blowout. Average daily volume of 29.4 million contracts was the highest third-quarter ADV in the company’s history, up 16% year over year, with double-digit growth in all six asset classes. Revenue rose 13% to $1.7 billion, adjusted operating income was $1.2 billion, and adjusted diluted EPS came in at $3.02, up 13%. Quarter-end open interest reached 128 million contracts and was already above 133 million by the call date. Terry Duffy framed the backdrop as “shifting central bank policies, geopolitical uncertainty, and persistent market volatility” — Terry Duffy, Chairman and Chief Executive Officer · 2026-10-21—a global hiking cycle that keeps pushing institutions to hedge. Yet the stock is not a fresh breakout. CME shares are up 11.2% over the last 90 trading days, but still 9.4% below the March 2 peak of $326.46. At 18.4x trailing earnings, down 30% year on year, the market had already paid for a good quarter. The story is less about the record and more about what is compounding underneath it—and what is stuck.Collateral efficiency is the product
The most important number on the call was not volume. It was the “over $100 billion a day in margin savings” — Terry Duffy, Chairman and Chief Executive Officer · 2026-10-21 CME delivered to customers, up from roughly $40 billion not long ago, by Duffy’s own recollection. That is the moat: CME is increasingly a collateral-efficiency utility, not just a venue. The equity complex alone generated just under $47 billion of savings in the quarter; portfolio margining in swaps hit a record $14 billion of daily savings on September 30; and the FICC cross-margin program averaged $2.3 billion a day. The company’s own keyword trajectory reflects this—margin program was the top-ranked CME theme this quarter, ahead of equity index and Compute Futures. The next leg is plumbing. Mike Dennis said Treasury Link is “live now in our new release environment, and clients have been testing the functionality this week” — Mike, Senior Executive (likely Rates or Treasury Products) · 2026-10-21, connecting Treasury futures and BrokerTec cash Treasuries on Globex. CME Securities Clearing is on track for December 7, ahead of the SEC’s Treasury clearing mandate. Those are not flashy products, but they deepen the same pool of collateral that makes the margin savings possible. The quiet revenue lever is market data: $243 million, up 20%, the 34th consecutive quarter of year-over-year growth. Julie Winkler broke the growth into thirds—professional subscribers, retail and simulation platforms, and data-feed/pricing/policy changes—which is a healthier mix than a single price increase. And the October 1 pricing changes should add “somewhere in the range of 0.5%-1% of the clearing and transaction fees” — Lynne Fitzpatrick, Chief Financial Officer · 2026-10-21 on an annualized basis.The innovation queue: Single Stock moves, Compute waits, perps fade
The clearest new-product traction is Single Stock futures. CME has traded a little over 350,000 contracts and about $3.5 billion of notional since launch, across 55 large-cap names in a 100-share multiplier and 22 names in a 10-share size. Distribution is the point: 130-plus retail firms, 25 top retail broker partners already live, and additional FCMs coming in Q4. That is a real product ramp, not a press release. Compute Futures is the opposite story. It remains the company’s highest-concept idea—a benchmark for the spot hourly rental cost of NVIDIA H100 GPUs, with Silicon Data as the index provider—but it is still sitting at the CFTC under a 40.3 full review, with the comment period extended to November 9. In the prior quarter, Derek Sammann was explicit that CME would be “the first daily benchmark tracking the spot hourly rental cost of NVIDIA H100 GPUs” — Derek Sammann, Global Head of Commodities & Options Products · 2026-07-22. This quarter, Duffy’s tone was more resigned.Derek still says “this product has a significant amount of client demand, and the Street is eager to be able to access these” — Derek, Senior Executive (likely Product or Client Development) · 2026-10-21, but the keyword Compute Futures has shifted from a launch narrative to a long game. The contrast with the tape is uncomfortable: the broader data centers and AI infrastructure trade has cooled over the last 90 days, so the product may arrive after the most urgent phase of the theme. Perpetuals are the bigger tell. In the prior quarter, Duffy spent much of the Q&A arguing that clients did not want the product. “They do not want this product. They do not know how they would possibly risk manage the exposures that they have on their books on it with a perpetual contract.” — Terry Duffy, Chairman & Chief Executive Officer · 2026-07-22 A quarter earlier, he had been even blunter: “perpetuals are against the law in the United States of America.” — Terrence Duffy, Chairman and Chief Executive Officer · 2026-04-22 This quarter, Perpetual futures fell sharply out of CME’s top keyword set—one of the largest conceptual decliners—and Duffy would only say, “We’ll make that decision if and when the time comes... we will cross that bridge when we get to it.” — Terry Duffy, Chairman and Chief Executive Officer · 2026-10-21 The lawsuit is still live, with a motion to dismiss briefed and expected before the judge in December. But the public emphasis has moved from fighting perps to waiting for the court. That is a meaningful change in posture, even if the legal position has not changed.We think this is a product that needs to get out... I would hope that the government would allow this product to move forward sooner rather than later. But again, it’s in their hands right now.